Melanie Klein-Chautard

Melanie Klein-Chautard has a diverse work experience in the fields of clinical operations, research, and immunotherapy. Melanie is currently working at Kayentis as a Business Unit Manager, responsible for overseeing the clinical operations project management team. Prior to this, they were a Manager in the Clinical Operations Project Management team at Kayentis. Before joining Kayentis, Melanie worked at ERYTECH Pharma, where they served as an R&D Project Manager. Their role involved managing research and development projects. Melanie also worked as an Associate Research Scientist and Research Engineer in Immunotherapy at ERYTECH Pharma. Additionally, Melanie has experience as a Research Engineer in Immuno-oncology at PDC*line Pharma and as a Research Engineer in training at Etablissement Francais du Sang/INSERM U823. Their role in these positions focused on the mechanism of action and optimization of therapeutic vaccines. Melanie also worked as a Research Engineer in training at INSERM U836, where they focused on the development of new cell lines for cell-based therapy. Melanie began their career as an intern at the University of Joseph Fourier, Grenoble, where they gained experience in cell engineering and protein engineering.

Melanie Klein-Chautard completed their Bachelor of Arts (B.A.) degree in Physical and Biological Anthropology at the University of Michigan from 2007 to 2011. Melanie then pursued further studies at Université Joseph Fourier (Grenoble I), where they obtained a Bachelor of Science (BSc) degree in Biology, General from 2012 to 2013. Melanie continued their education at the same institution, completing a Master's degree in Biotechnology from 2013 to 2015.